Advertisement

Topics

AstraZeneca: FASENRA Gets US FDA Approval For Severe Eosinophilic Asthma

20:05 EST 14 Nov 2017 | FinanzNachrichten

LONDON (dpa-AFX) - AstraZeneca (AZN, AZN.L) and its global biologics research and development arm, MedImmune, said Tuesay that the US Food and Drug Administration has approved FASENRA (benralizuma...

Original Article: AstraZeneca: FASENRA Gets US FDA Approval For Severe Eosinophilic Asthma

NEXT ARTICLE

More From BioPortfolio on "AstraZeneca: FASENRA Gets US FDA Approval For Severe Eosinophilic Asthma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...